Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
Cost of Revenue
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501
|
Cost of Revenue
-¥762.6m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
C
|
China Hongqiao Group Ltd
HKEX:1378
|
Cost of Revenue
-¥112.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
Shandong Nanshan Aluminium Co Ltd
SSE:600219
|
Cost of Revenue
-¥23B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-6%
|
|
A
|
Aluminum Corporation of China Ltd
SSE:601600
|
Cost of Revenue
-¥197.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-2%
|
Yunnan Aluminium Co Ltd
SZSE:000807
|
Cost of Revenue
-¥36B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-10%
|
|
Tianshan Aluminum Group Co Ltd
SZSE:002532
|
Cost of Revenue
-¥24.8B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-87%
|
CAGR 10-Years
-40%
|
See Also
What is Shanghai Haishun New Pharmaceutical Packaging Co Ltd's Cost of Revenue?
Cost of Revenue
-762.6m
CNY
Based on the financial report for Sep 30, 2023, Shanghai Haishun New Pharmaceutical Packaging Co Ltd's Cost of Revenue amounts to -762.6m CNY.
What is Shanghai Haishun New Pharmaceutical Packaging Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-20%
Over the last year, the Cost of Revenue growth was -10%. The average annual Cost of Revenue growth rates for Shanghai Haishun New Pharmaceutical Packaging Co Ltd have been -19% over the past three years , -20% over the past five years .